Home   /   Patents & licensing
Patents & licensing

Protecting discovery.
Enabling what comes next.

Patents granted and applications published to Bordoloi Biotech LLC (USA), alongside selected intellectual property from Dr. Bordoloi’s research career.

Patents granted (and applications published) to Bordoloi Biotech LLC (USA):

B. Herbal / Botanical and Prescription Rx Molecules on Breast Cancer

  • Application # 63/992,244 (February 27, 2026): COMPOSITION AND METHOD FOR TREATING CANCER
  • Citral & epicurzerenone induce apoptosis in MCF-7 cells, & CITRAL EXHIBITS ANTITUMOR EFFICACY IN AN ORTHOTOPIC EMT6 MURINE BREAST CANCER MODEL

Additional intellectual property

Patents assigned to Johnson & Johnson (USA)

Surgical sealants, synthetics and biological products: US 8,846,849; US 8,337,881; US 8,129,445; US 7,947,758; US 7,868,123.

Cosmetics and topical consumer products: US 8,834,943; US 8,344,031; US 8,278,359; US 8,221,046; US 8,163,313.

Technology licensed to BBIPL (India)

Herbal Ayurvedic composition: Anti-inflammatory activity with synergism of herbal essential oils.

Other areas

Silicone chemistry of elastomers and nanomaterials, including US 10,167,413, Ice-phobic coating formulations and uses thereof (assigned to Ames Corp.). Acrylic chemistry for elastomers, adhesives and coatings includes EP 0263686 B1, US 5,187,235 A, EP 0239633 B1 and US 4,714,655 (assigned to Avery Dennison Corp.).

Let’s move science forward

Progress begins with a conversation.

Explore research collaborations, patent licensing and product development.

Connect with our team